MRNA
MRNA
NASDAQ · Biotechnology

Moderna Inc

$54.35
+5.81 (+11.97%)
As of May 9, 1:06 AM ET ·
Day Range $48.98 — $57.78
52W Range $22.28 — $59.55

Performance

1D
1W
1M
3M +29.56%
6M +119.51%
1Y +124.12%
YTD +76.12%
Open$49.00
Previous Close$48.54
Day High$57.78
Day Low$48.98
52W High$59.55
52W Low$22.28
Volume
Avg Volume6.14M
Market Cap21.57B
P/E Ratio
EPS$-8.15
SectorBiotechnology

Technical Indicators

Full analysis →
SMA 50 $37.98 Above
SMA 200 $29.64 Above
RSI (14) 57.2 Neutral
Trend Golden Cross Bullish

Analyst Ratings

Hold
30 analysts
3 Buy 21 Hold 6 Sell
Price Target +175.0% upside
Current
$54.35
Target
$149.45
$89.97 $149.45 avg $212.09

Key Financials

FY 2026 FY 2025 FY 2024
Revenue 1.98B 4.26B 2.23B
Net Income -2,878,486,025 -5,564,083,811 -285,156,561
Profit Margin -145.2% -137.9% -12.8%
EBITDA -2,909,078,247 -5,935,619,275 -355,384,473
Free Cash Flow -237,052,091
Rev Growth -53.4% -53.4% +3.0%
Debt/Equity 0.07 0.07 0.52

Biotechnology Peers

Symbol Name Price Change P/E Mkt Cap
ABBV Abbvie Inc $201.55 -0.57% 88.1 372.29B
AMGN Amgen Inc $331.70 +0.79% 22.7 176.88B
GILD Gilead Sciences Inc $131.33 -2.04% 19.3 163.92B
VRTX Vertex Pharmaceuticals Inc $429.82 +1.13% 27.7 109.50B
REGN Regeneron Pharmaceuticals $714.89 +0.82% 16.5 74.30B
ALNY Alnylam Pharmaceuticals Inc $295.05 -0.29% 130.4 40.90B